$SNCE News
Last published 1y ago
- 1y agoSNCEScience 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease TrialGlobeNewswireMORRISVILLE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, today announced the successful completion of its third FDA inspection, further affirming the
- 1y agoSNCEEarnings Call - SCIENCE 37 HOLDINGS INCEarnings Call TranscriptsThank you very much. It's a pleasure to be here. So my name is PJ Brooks. I'm from the National Center for Advancing Translational Sciences. I've been the acting director of the Division of Rare Disease Research Innovati
- 1y agoSNCEScience 37 and Catalent Announce Partnership Enabling Universal Access to Clinical ResearchGlobeNewswireMORRISVILLE, N.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, and Catalent®, a global leader in enabling pharma, biotech, and consumer health partners
- 1y agoSNCEScience 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma TrialGlobeNewswireMORRISVILLE, N.C., April 08, 2025 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, today announced the successful completion of its second FDA inspection, reaffirming the quality
- 1y agoSNCEScience 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access InnovationGlobeNewswireMORRISVILLE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, announces the appointment of Tyler Van Horn as Chief Executive Officer. Formerly the company's
- 1y agoSNCEScience 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease TrialGlobeNewswireMORRISVILLE, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, was a key enrolling site for the primary completion of a Phase 3 rare disease trial sponsored by
- 2y agoSNCEScience 37 Earns Frost & Sullivan's 2024 Global Company of the Year Award for Decentralized Clinical TrialsGlobeNewswireMORRISVILLE, N.C., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Today, Science 37, a leader in enhancing patient access to clinical trials, announced that it has received Frost & Sullivan's 2024 Global Company of the Year
- 2y agoSNCEScience 37 Unveils New Corporate Headquarters in Research Triangle Park, NCGlobeNewswireMORRISVILLE, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, today announced the grand opening of its new, 19,000-square-foot corporate headquarters in
- 2y agoSNCEScience 37 Enrolls 42% of Trial Cohort in 8 WeeksGlobeNewswireMORRISVILLE, N.C., July 18, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, disclosed the final figures resulting from its partnership with a biopharmaceutical company
- 2y agoSNCEScience 37 Quickly Impacts Performance in Under-Enrolling Clinical TrialsGlobeNewswireRESEARCH TRIANGLE PARK, N.C., June 27, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, has been added to over 20 studies that were lagging in recruitment, helping them to
- 2y agoSNCEScience 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical TrialGlobeNewswireRESEARCH TRIANGLE PARK, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc., a leader in enhancing patient access to clinical trials, announced the final enrollment figures from its 20-month engagement
- 2y agoSNCEScience 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and ComplianceGlobeNewswireRESEARCH TRIANGLE PARK, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. today announced the preliminary outcome of its recent FDA Inspection focusing on critical areas and documentation. The nearly
- 2y agoSNCEScience 37 Wins 2024 MedTech Breakthrough Award for "Clinical Efficiency Innovation"GlobeNewswireScience 37's Patient Recruitment Recognized in Prestigious International Annual Awards Program for Standout Digital Health & Medical Technology Products and Companies RESEARCH TRIANGLE PARK, N.C., May 09, 2024
- 2y agoSNCEScience 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical TrialGlobeNewswireRESEARCH TRIANGLE PARK, N.C., May 02, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. today disclosed the latest enrollment figures resulting from its Metasite™ and Patient Recruitment partnership with a
- 2y agoSNCEScience 37 Provides Fully Consented Patients to Sites to Supplement EnrollmentGlobeNewswireRESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc., the clinical research industry's leading MetasiteTM, today announced the launch of a stand-alone Patient Recruitment Solution
- 2y agoSNCEeMed completes tender offer for all outstanding shares of Science 37PR NewswireeMed, LLC ("eMed") today announced the successful completion of the previously announced tender offer by its wholly-owned subsidiary, Marlin Merger...
- 2y agoDFSSNCEHRTIONMKuehn Law Encourages DFS, SNCE, HRT, and IONM Investors to Contact Law FirmPR NewswireKuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may...
- 2y agoBATLKAMNKRTXSNCEKuehn Law Encourages KAMN, SNCE, KRTX, and BATL Investors to Contact Law FirmGlobeNewswireNEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
- 2y agoSNCEeMed commences tender offer for Science 37PR NewswireeMed, LLC ("eMed") today announced that its wholly-owned subsidiary, Marlin Merger Sub Corporation, a Delaware corporation ("Purchaser"), has...
- 2y agoKRTXMGRCSNCEVINEKuehn Law Encourages SNCE, MGRC, VINE, and KRTX Investors to Contact Law FirmGlobeNewswireNEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
- 2y agoSNCEScience 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating EnrollmentGlobeNewswireRESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE) (the "Company" or "Science 37"), the clinical research industry's leading MetasiteTM, today announced that it has
- 2y agoSNCEScience 37 Receives Top Honors in Everest PEAK Matrix®GlobeNewswireRESEARCH TRIANGLE PARK, N.C., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the clinical research industry-leading Metasite™ today announced that it has been named a Leader in the
- 2y agoSNCEScience 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireRESEARCH TRIANGLE PARK, N.C., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the Science
- 2y agoSNCEScience 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023GlobeNewswireRESEARCH TRIANGLE PARK, N.C., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE) ("Science 37" or the "Company"), the clinical research industry-leading Metasite™, announced today that it
- 3y agoSNCEScience 37 Holdings, Inc. (SNCE) Q3 2023 Earnings Call TranscriptEarnings Call Transcripts
- 3y agoSNCEScience 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireRESEARCH TRIANGLE PARK, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the Science
- 3y agoSNCEScience 37 Reports Third Quarter 2023 Financial ResultsGlobeNewswireRESEARCH TRIANGLE PARK, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), ("Science 37"), the industry-leading Metasite™, today reported its financial results for the quarter ended
- 3y agoSNCEScience 37 to Report Third Quarter 2023 Financial Results on November 7, 2023GlobeNewswireRESEARCH TRIANGLE PARK, N.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™ today announced it will report third quarter 2023 financial results prior
- 3y agoSNCEScience 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireRESEARCH TRIANGLE PARK, N.C., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the Science
- 3y agoSNCEScience 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 ListGlobeNewswireRESEARCH TRIANGLE PARK, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the clinical research industry-leading Metasite™, today announced that its Chief Delivery Officer, Darcy
- 3y agoSNCEScience 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023GlobeNewswireRESEARCH TRIANGLE PARK, N.C., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Science 37 announced today that it has been recognized in the Gartner Hype Cycle for Life Science Clinical Development, 2023. As stated by Gartner, "This
- 3y agoSNCEScience 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & SullivanGlobeNewswireRESEARCH TRIANGLE PARK, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the clinical research industry-leading Metasite™, today announced that it has been honored with the
- 3y agoSNCEScience 37 to Participate in H.C. Wainwright 25th Annual Global Investment ConferenceGlobeNewswireRESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming H.C.
- 3y agoSNCEScience 37 Recognized as Best Digital Health Solution Nominee at 2023 Prix Galien USA AwardsGlobeNewswireRESEARCH TRIANGLE PARK, N.C., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the clinical research industry-leading Metasite™ is proud to announce its nomination for the prestigious
- 3y agoSNCEScience 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireRESEARCH TRIANGLE PARK, N.C., Aug. 11, 2023 (GLOBE NEWSWIRE) -- August 11, 2023—Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards
- 3y agoSNCEScience 37 Reports Second Quarter 2023 Financial ResultsGlobeNewswireRESEARCH TRIANGLE PARK, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), ("Science 37"), the industry-leading Metasite™, today reported its financial results for the quarter ended
- 3y agoSNCEScience 37 to Report Second Quarter 2023 Financial Results on August 8, 2023GlobeNewswireRESEARCH TRIANGLE PARK, N.C., July 25, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™ today announced it will report second quarter 2023 financial results prior
- 3y agoSNCESYBXSynlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU)GlobeNewswireRESEARCH TRIANGLE PARK, N.C., July 11, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the clinical research industry-leading Metasite™ has been chosen by Synlogic, (NASDAQ:SYBX), a
- 3y agoSNCEScience 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireRESEARCH TRIANGLE PARK, N.C., July 07, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the Science
- 3y agoSNCEScience 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireRESEARCH TRIANGLE PARK, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the Science
- 3y agoSNCEScience 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform"GlobeNewswireRESEARCH TRIANGLE PARK, N.C., May 18, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the clinical research industry-leading Metasite™, has been named the winner of the prestigious "Best
- 3y agoSNCEScience 37 Reports First Quarter 2023 Financial ResultsGlobeNewswireRESEARCH TRIANGLE PARK, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), ("Science 37"), the industry-leading Metasite™, today reported its financial results for the quarter ended
- 3y agoSNCEScience 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswireRESEARCH TRIANGLE PARK, N.C., May 05, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the Science
- 3y agoSNCEScience 37 Joins Partnership in Support of White House CancerX and Cancer MoonshotGlobeNewswireRESEARCH TRIANGLE PARK, N.C., May 02, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading MetasiteTM, today announced its partnership with the Digital Medicine Society (DiMe) in
- 3y agoSNCEScience 37 to Report First Quarter 2023 Financial Results on May 15, 2023GlobeNewswireRESEARCH TRIANGLE PARK, N.C., May 01, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™ today announced it will report first quarter 2023 financial results prior to
- 3y agoSNCEScience 37 Appoints SVP, Erica Prowisor, to Bolster Patient Recruitment Velocity, DiversityGlobeNewswireRESEARCH TRIANGLE PARK, N.C., April 25, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™, announced today Erica Prowisor as SVP of Patient and Provider Networks to
- 3y agoSNCEScience 37 Collaborates with AWS to Enable Faster, Patient-Friendly, Clinical ResearchGlobeNewswireRESEARCH TRIANGLE PARK, N.C., April 20, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the clinical research industry-leading Metasite™, today announced a multi-year relationship with Amazon
- 3y agoSNCEScience 37 Adds New Head of Quality, Irena LambridisGlobeNewswireRESEARCH TRIANGLE PARK, N.C., April 18, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™, today announced the appointment of Irena Lambridis as its Global Head of
- 3y agoSNCEScience 37 to Host Business Update Call on April 12, 2023GlobeNewswireRESEARCH TRIANGLE PARK, N.C., April 11, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™ today announced it will host a business update conference call prior to
- 3y agoSNCEScience 37 Unveils Three Global Centers of Excellence to Drive Efficiency, Speed and QualityGlobeNewswireRESEARCH TRIANGLE PARK, N.C., April 11, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (NASDAQ:SNCE), the industry-leading Metasite™, today unveiled three global Centers of Excellence (COEs) to gain greater